A federal court determined that Roca Labs pocketed $25,246,000 (roughly the annual salary of 400 median American workers) by selling a supplement it could not scientifically prove did anything at all, then sued the very customers who tried to warn others.

A Supplement Empire Built on Invented Science

Roca Labs, Inc. and its web of related shell companies, including Roca Labs Nutraceutical USA, Inc., Must Cure Obesity Co., Juravin Incorporated, and Zero Calorie Labs, Inc., sold a powdered dietary supplement under names including “Gastric Bypass Alternative,” “Gastric Bypass No Surgery,” and “Gastric Bypass Effect.” The marketing was deliberate and targeted at the most vulnerable possible consumer: people in genuine medical distress about their weight, people who could not afford bariatric surgery, and people who desperately wanted a solution.

The company’s two key individuals were Don Juravin, who held majority control and operational authority over the entire enterprise, and George C. Whiting, who served as an officer of Roca Labs, Inc., Roca Labs Nutraceutical USA, Inc., and Zero Calorie Labs, Inc. The court treated them as the architects of the scheme. The corporate structure, with its multiple overlapping entities, appears designed to diffuse legal liability across as many shells as possible.

The product was marketed as doing what it literally could not be proven to do. The court found that Defendants lacked a reasonable basis for five separate express, material weight-loss claims about their products because they lacked competent and reliable scientific evidence. That is the legal way of saying: they made it all up.

The Claims Were Specific, Dramatic, and False

Roca Labs did not deal in vague promises. The court’s findings list specific, numbered claims the company made without evidence: weight loss of as much as 21 pounds in a month ($20 worth of actual groceries, gone, by corporate decree), as much as 100 pounds in ten months, a reduction of food intake by as much as 50%, and a 90% success rate across users. These were not footnoted caveats. They were core marketing claims splashed across the company’s websites.

The company also claimed the product produced weight-loss benefits “comparable or superior to bariatric surgery.” Bariatric surgery is a serious, medically supervised procedure. Roca Labs claimed a supplement drink matched or beat it. The court permanently banned the defendants from making any such claim again without randomized, double-blind, placebo-controlled human clinical trials to back it up.

They Sued the Customers Who Dared Tell the Truth

When a product fails, a decent company issues a refund and works to improve. Roca Labs deployed lawyers. The company embedded non-disparagement clauses inside its online sales contracts, then threatened and filed lawsuits against dissatisfied customers who posted honest negative reviews online. The court found that this conduct “unfairly suppressed negative information about the Defendants and their products, to the detriment of subsequent purchasers.”

Think about that mechanism for a moment. Person A buys the supplement, it doesn’t work, Person A posts a warning online. Roca Labs sues Person A. Person B, who hasn’t bought yet, now searches for reviews and finds nothing. Person B buys the supplement. The predatory loop closes. The company described the non-disparagement obligation as something customers had already agreed to in exchange for a “substantial discount.” The court found that representation was also false.

The company went further. The final order permanently bans Roca Labs from representing that any customer could be “liable for defamation or other legal liability for speaking or publishing any statement that the Covered Product was ineffective.” That ban exists because the company was already making exactly that threat, to real people, in real communications.

The Fake Independent Website No One Knew They Owned

Roca Labs operated a website at Gastricbypass.me, which the court specifically names in the permanent injunction, and presented it to prospective customers as an independent, objective resource for research and scientific information. The site was neither independent nor objective. Roca Labs controlled it. The company used it to funnel curious, researching consumers toward buying the product while concealing that the “research resource” was, functionally, a store page.

The company also paid people to serve as “testimonialists,” then deployed those paid endorsers as if they were ordinary, unpaid customers sharing real experiences. The court found that Roca Labs “deceptively failed to disclose their financial relationship to testimonialists who worked for them.” These were not enthusiastic customers. They were compensated brand representatives whose connection to the company was never disclosed to the people reading their words.

What Money Cannot Measure: The Cost to Real People

The $25,246,000 (enough money to provide health insurance to over 1,400 uninsured Americans for a decade) judgment is a number on a court document. It says nothing about what it feels like to be a person struggling with your weight, someone who has been told by doctors that bariatric surgery is medically appropriate but costs $15,000 to $25,000 out of pocket, and who finds a website claiming that a powder drink can replicate that surgical outcome for a fraction of the price. That person is not naive. That person is desperate and rational. Roca Labs specifically targeted them.

The company’s marketing vocabulary was engineered for that desperation. “Gastric Bypass No Surgery.” “Gastric Bypass Effect.” “Bariatric Surgery Alternative.” Every product name in their lineup was designed to activate the hope of someone who had already been told by the medical system that the help they needed was financially out of reach. They paid for something that promised to close the gap between what they could afford and what they needed. They received a supplement with no proven efficacy and a contract clause that threatened to bankrupt them if they complained.

The non-disparagement clause was not a neutral business protection. The court’s findings make clear it was deployed as a weapon. Customers who wrote honest negative reviews faced the threat of lawsuits, debt collection for the supposed “full price” of the product (in excess of the “discounted” amount they paid), and the suggestion that their truthful speech constituted a legally actionable breach of contract. For an ordinary working person, receiving a legal threat is not a minor inconvenience. It is a crisis. The cost of defending even a frivolous lawsuit starts at thousands of dollars. Roca Labs knew this. That asymmetry was the weapon.

The privacy violation compounds the picture. The court permanently banned Roca Labs from “misrepresenting the extent to which they maintain the confidentiality of consumer information.” The company had collected highly personal health data from customers who, by definition, were disclosing sensitive information about their bodies and medical histories in the process of purchasing. They shared that intimate information with a company that promised to protect it, then learned that promise was also subject to misrepresentation. The people Roca Labs targeted gave them their bodies and their trust. The court’s record shows the company treated both as raw material.

Straight from the Court Document: The Damning Passages

“[Defendants] falsely claimed that use of their products is scientifically proven to have a ninety-percent success rate in forcing users to eat half their usual food intake and cause substantial weight loss.”

Court Finding — FTC v. Roca Labs, Inc., Summary Judgment Order, September 14, 2018

“[Defendants] unfairly suppressed negative information about the Defendants and their products, to the detriment of subsequent purchasers, by making threats to sue and filing of lawsuits against dissatisfied consumers for violating non-disparagement clauses in their online sales contracts.”

Court Finding — FTC v. Roca Labs, Inc., Summary Judgment Order, September 14, 2018

“[Defendants] deceptively failed to disclose their financial relationship to testimonialists who worked for them, and their control of a supposedly independent and objective information website that they used to promote their products.”

Court Finding — FTC v. Roca Labs, Inc., Summary Judgment Order, September 14, 2018

“[Defendants] misrepresented that consumers had agreed to non-disparagement clauses in exchange for a substantial discount on the products.”

Court Finding — FTC v. Roca Labs, Inc., Summary Judgment Order, September 14, 2018

“The Court found that the proper amount of equitable monetary relief against all the Defendants, except George C. Whiting, is $25,246,000, a sum that the Court found to be a reasonable approximation of the Defendants’ unjust gains from their unlawful practices.”

Final Judgment and Order for Permanent Injunction — FTC v. Roca Labs, Inc., January 4, 2019

“Between March 21, 2016 and August 2, 2016, Defendant Must Cure Obesity Co. transferred approximately $295,688.00 to a third party, Jugaad Co., in violation of the asset preservation provisions of the Court’s October 29, 2015 preliminary injunction.”

Court Finding — FTC v. Roca Labs, Inc., Final Judgment, January 4, 2019

The Damage Beyond One Company’s Bank Account

Public Health: Exploiting the Gap Between Need and Access

The Roca Labs scheme operates at the precise intersection of two public health failures: the obesity epidemic and the unaffordability of treatment for it. Bariatric surgery costs tens of thousands of dollars and is frequently denied by insurance. The FDA does not pre-approve dietary supplements for safety or efficacy before they reach the market. Into that gap, Roca Labs inserted a product it claimed was “comparable or superior to bariatric surgery” with zero clinical evidence. The court’s final order now requires that any weight-loss efficacy claim be backed by “randomized, double-blind, and placebo-controlled” human clinical testing. That standard did not exist for Roca Labs’ customers before they paid.

The product names themselves reveal the public health targeting strategy. “Gastric Bypass No Surgery” is not a generic brand name. It is a direct response to the specific barrier most people face when told they need bariatric intervention: the word “surgery.” People searching for non-surgical weight-loss alternatives, many of them clinically obese, many of them facing real metabolic and cardiovascular risk, were steered toward an unproven supplement. The harm is not merely financial. People who spent money on Roca Labs’ product instead spent time in a false solution. That time has a medical cost.

The court also found that Roca Labs claimed the product was “safe and effective for weight loss in children.” The court permanently banned this claim. A company that marketed an unproven supplement to children, under the branding of a surgical alternative, represents a specific and serious public health threat. The supplement industry’s lack of pre-market FDA testing creates the legal space for exactly this kind of claim. Roca Labs used that space aggressively, deliberately, and without scientific basis.

Economic Inequality: How Desperation Becomes a Revenue Model

The $25,246,000 (roughly what it would cost to send 840 kids to four-year public universities) that the court identified as “unjust gains” did not come equally from across the economic spectrum. Bariatric surgery is inaccessible primarily to people without comprehensive health insurance or the savings to cover it out of pocket. Roca Labs positioned its product specifically for those people. The supplement’s price point, marketed with a “discount” structure the court found was itself misrepresented, was designed to feel attainable to someone who could never afford surgery.

The non-disparagement clause enforcement mechanism doubled down on this economic exploitation. When Roca Labs threatened to bill customers for the “full price” of the product (above the discounted amount charged at purchase), it weaponized the very financial precarity of its customer base. People who could barely afford the supplement in the first place were threatened with additional debt simply for telling the truth about their experience. The legal threat cost Roca Labs almost nothing to send. For its targets, a threatened lawsuit represented a potentially catastrophic financial event. That power imbalance was the entire point.

The bankruptcy filings by Roca Labs, Inc. and Don Juravin further illustrate this inequality. The people who were deceived wait in a queue of creditors, their potential redress filtered through bankruptcy proceedings, while the mechanisms of corporate law that the company used to structure multiple interlocking entities (Roca Labs, Inc.; Roca Labs Nutraceutical USA, Inc.; Must Cure Obesity Co.; Juravin Incorporated; Zero Calorie Labs, Inc.) make collection difficult. A single working person who bought the supplement cannot structure their losses across five corporate shells. The company could. That asymmetry survives the judgment.

The Price of the Fraud

Who Is Watching, and What You Can Do

Corporate Roles Still Named in This Case

• Don Juravin, Individual Defendant and majority controller of Roca Labs, Inc.; currently in Chapter 7 bankruptcy proceedings (Case No. 6:18-bk-06821).
• George C. Whiting, Individual Defendant and officer of Roca Labs, Inc., Roca Labs Nutraceutical USA, Inc., and Zero Calorie Labs, Inc. (not named in the monetary judgment; named in the permanent injunction).
• Corporate Defendants: Roca Labs, Inc. (Chapter 7 bankruptcy); Roca Labs Nutraceutical USA, Inc.; Must Cure Obesity Co.; Juravin Incorporated; Zero Calorie Labs, Inc.

Watchlist: Regulatory Bodies

• Federal Trade Commission (FTC): Filed this case and holds enforcement authority over the permanent injunction. Report consumer fraud at reportfraud.ftc.gov.
• U.S. Food and Drug Administration (FDA): Regulates dietary supplement labeling. Report misleading supplement claims at fda.gov/safety/report-problem-fda.
• Consumer Financial Protection Bureau (CFPB): Covers deceptive financial practices tied to consumer purchases. File complaints at consumerfinance.gov/complaint.
• State Attorneys General: Many states have their own consumer protection bureaus that can act on supplement fraud independently of federal enforcement.

On the Ground

Federal judgments are important. Grassroots pressure is what gives them teeth. Connect with local consumer protection organizations and mutual aid networks that support low-income people navigating healthcare costs and predatory marketing. Share verified information about supplement fraud on community boards, neighborhood apps, and local social networks where the most vulnerable consumers actually search for product reviews. The suppression of honest reviews was Roca Labs’ most powerful tool. Restoring those voices through peer-to-peer communication is the most direct counter to it.